A 6-year-old child presents with intense pruritus, lichenified plaques on the flexural surfaces of the elbows and knees, and a history of allergic rhinitis. Skin prick testing confirms sensitization to house dust mites. What is the first-line topical agent for acute flares in this patient?

Explanation

## First-Line Topical Therapy in Atopic Dermatitis **Key Point:** Topical corticosteroids remain the gold standard and first-line treatment for acute flares of atopic dermatitis across all age groups, including children. ### Rationale for Corticosteroids 1. **Rapid anti-inflammatory action** — suppress Th2-mediated inflammation and reduce pruritus within 24–48 hours 2. **Potency selection** — mild-to-moderate potency (Class III–IV) for flexural areas in children; avoid super-potent agents on thin-skinned areas 3. **Cost-effectiveness** — inexpensive, widely available, and proven efficacy over decades 4. **Evidence base** — Level 1 evidence supports topical corticosteroids as first-line in all international guidelines (AAD, EADV, Indian Academy of Dermatology) ### Stepwise Approach in AD | Severity | First-Line | Second-Line | Third-Line | |----------|-----------|------------|------------| | **Mild** | Emollients + mild TCS | Calcineurin inhibitors | Phototherapy | | **Moderate** | Emollients + moderate TCS | Calcineurin inhibitors | Systemic agents | | **Severe** | Emollients + potent TCS | Systemic corticosteroids, cyclosporine, dupilumab | Biologic agents | **Clinical Pearl:** In children, always use the "steroid-sparing" principle — use the lowest potency corticosteroid that controls the flare, combined with regular emollients to prevent relapse. **High-Yield:** Calcineurin inhibitors (tacrolimus, pimecrolimus) are **steroid-sparing alternatives**, not first-line, and are reserved for: - Corticosteroid-induced atrophy concerns - Facial/intertriginous involvement - Patients with contraindications to topical steroids **Mnemonic: "TCS First, Then Spare"** — Topical Corticosteroids are first-line; use Steroid-sparing agents (calcineurin inhibitors) only after or alongside to reduce long-term steroid burden.